首页> 美国卫生研究院文献>The EMBO Journal >Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy
【2h】

Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy

机译:VEGF的条件转换为成人新血管形成和促血管生成治疗提供了新见识

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To gain insight into neovascularization of adult organs and to uncover inherent obstacles in vascular endothelial growth factor (VEGF)-based therapeutic angiogenesis, a transgenic system for conditional switching of VEGF expression was devised. The system allows for a reversible induction of VEGF specifically in the heart muscle or liver at any selected schedule, thereby circumventing embryonic lethality due to developmental misexpression of VEGF. Using this system, we demonstrate a progressive, unlimited ramification of the existing vasculature. In the absence of spatial cues, however, abnormal vascular trees were produced, a consequence of chaotic connections with the existing network and formation of irregularly shaped sac-like vessels. VEGF also caused a massive and highly disruptive edema. Importantly, premature cessation of the VEGF stimulus led to regression of most acquired vessels, thus challenging the utility of therapeutic approaches relying on short stimulus duration. A critical transition point was defined beyond which remodeled new vessels persisted for months after withdrawing VEGF, conferring a long-term improvement in organ perfusion. This novel genetic system thus highlights remaining problems in the implementation of pro-angiogenic therapy.
机译:为了深入了解成年器官的新血管形成并发现基于血管内皮生长因子(VEGF)的治疗性血管生成中的固有障碍,设计了有条件地转换VEGF表达的转基因系统。该系统允许在任何选定的时间表中特异性地在心肌或肝脏中可逆地诱导VEGF,从而避免由于VEGF的发育错误表达而导致的胚胎致死性。使用此系统,我们演示了现有脉管系统的渐进式,无限分支。然而,在没有空间提示的情况下,产生了异常的维管树,这是与现有网络混乱连接以及形成形状不规则的囊状血管的结果。 VEGF还引起大量且高度破坏性的水肿。重要的是,过早停止VEGF刺激会导致大多数获得血管的退化,从而挑战依赖短刺激持续时间的治疗方法的实用性。定义了一个关键的过渡点,在此过渡点之上,重构的新血管在撤回VEGF后将持续数月,从而使器官灌注长期改善。因此,这种新颖的遗传系统突出了促血管生成治疗实施中的剩余问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号